Rxo (RXO) Assets (2021 - 2026)

Rxo (RXO) has reported Assets for 6 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets rose 8.06% year-over-year to $3.5 billion; the trailing twelve-month figure through Jun 2026 stood at $3.5 billion (up 8.06% YoY), and the FY2025 full-year result was $3.3 billion, down 4.01% from the prior year.
• Assets rose to $3.5 billion in Q2 2026 per RXO's latest filing, from $3.3 billion in the prior quarter.
• Across five years, Assets topped out at $3.5 billion in Q2 2026 and bottomed at $1.8 billion in Q1 2024.
• Historically, Assets has averaged $2.6 billion across 5 years, with a median of $2.7 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Assets retreated 13.01% in 2023, then jumped 87.07% in 2024.
• Over 5 years, Assets stood at $2.0 billion in 2022, then slipped by 10.14% to $1.8 billion in 2023, then surged by 87.07% to $3.4 billion in 2024, then fell by 4.01% to $3.3 billion in 2025, then gained by 5.55% to $3.5 billion in 2026.
• According to Business Quant data, Assets over the past three periods registered $3.5 billion, $3.3 billion, and $3.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.